Summary of MERIDIAN BIOSCIENCE INC

Item 2.02. Results of Operations and Financial Condition.

On July 16, 2009, the Registrant issued a press release announcing announcing its financial results for the fiscal quarter ended June 30, 2009. A copy of the press release is furnished as Exhibit 99 to this report and is incorporated herein by reference.

Item 5.02 Departure of Directors or Certain Officers; Election Of Directors;
Appointment Of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 16, 2009, the Board of Directors of the Company elected James M. Anderson as a director.

Mr. Anderson, age 67, is President and Chief Executive Officer of Cincinnati Children's Hospital Medical Center. His appointment as President and CEO in 1996 followed 20 years of service to the Cincinnati Children's board of trustees, including four years as chairman, as well as involvement on the Executive, Finance, Investment and Compensation, Personnel and Nominating committees. He was recently appointed chairman of the Board of the Cincinnati Branch of the Federal Reserve Bank of Cleveland.

Prior to joining the staff of Cincinnati Children's, Mr. Anderson was a partner in the general corporate department at an unrelated Cincinnati-based law firm for 24 years (1968-1977; 1982-96) and president of US operations at Xomox Corporation (1977-82), a publicly traded manufacturer of specialty process controls.

There is no arrangement or understanding between Mr. Anderson and any other person pursuant to which Mr. Anderson was elected as a director of the Company. There are no transactions in which Mr. Anderson has an interest requiring disclosure under Item 404(a) of Regulation S-K. Pursuant to its 2004 Equity Compensation Plan, the Company granted Mr. Anderson options to purchase 2,317 shares of common stock on July 16, 2009. The Board has not appointed Mr. Anderson to any committees at this time.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

The following exhibit is filed with this Current Report on Form 8-K:

Exhibit No. Description

99 Press Release dated July 16, 2009.